These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7131986)

  • 21. [Suppression of leukocyte chemotaxis by sera from patients with pulmonary sarcoidosis (author's transl)].
    Okuyama Y; Terai T; Yozawa H; Abe S; Osaki Y; Murao M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1982 Apr; 20(4):403-7. PubMed ID: 7109366
    [No Abstract]   [Full Text] [Related]  

  • 22. Possible afferent limb immune defect in sarcoid lymphocytes.
    Ogunye O; Young R
    East Afr Med J; 1982 Mar; 59(3):199-205. PubMed ID: 6982809
    [No Abstract]   [Full Text] [Related]  

  • 23. [Role of cellular reactions in detecting allergic reorganization of the body in specific and nonspecific lung diseases].
    Kogopova LS; Kostromina VP; Balitskaia NA; Varshavskaia EN
    Vrach Delo; 1973 Dec; 12():70-4. PubMed ID: 4787483
    [No Abstract]   [Full Text] [Related]  

  • 24. [Bronchial lavage--a method for studying the immunological processes of the lung].
    Thunell M; Bjermer L; Lundgren R
    Lakartidningen; 1984 Jul; 81(30-31):2741-3. PubMed ID: 6471973
    [No Abstract]   [Full Text] [Related]  

  • 25. [Considerations on various clinico-evolutive aspects of intrathoracic sarcoidosis].
    Salvati F; Storniello G; Coppi G; Mugnaimi L; Sbampato M; Nunziati F
    Recenti Prog Med; 1983 Nov; 74(11):1293-310. PubMed ID: 6369449
    [No Abstract]   [Full Text] [Related]  

  • 26. Further evidence against the concept of decreased phage neutralizing ability of serum of patients with sarcoidosis.
    Bowman BU; Daniel TM
    Am Rev Respir Dis; 1971 Dec; 104(6):908-14. PubMed ID: 5125591
    [No Abstract]   [Full Text] [Related]  

  • 27. [Biologic markers of sarcoidosis. Apropos of a case of pulmonary and cutaneous sarcoidosis].
    Guinand O; Hofer R; De Senarclens C
    Rev Med Suisse Romande; 1983 Sep; 103(9):737-42. PubMed ID: 6648182
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinicoimmunological comparisons in pulmonary sarcoidosis].
    Kostina ZI; Korol' OI; Ivanovskiĭ VB; Loshchinskaia NN
    Probl Tuberk; 1981 Oct; (10):21-4. PubMed ID: 6796954
    [No Abstract]   [Full Text] [Related]  

  • 29. [Sarcoidosis: immunopathology and criteria of biological activity].
    Müller-Quernheim J; Ménard O
    Rev Mal Respir; 1995; 12(6):525-31. PubMed ID: 8677346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Autoimmune thrombocytopenia in sarcoidosis].
    Glushko RA; Daurov BI; Rumiantsev VG
    Probl Tuberk; 1984 Aug; (8):73-4. PubMed ID: 6494131
    [No Abstract]   [Full Text] [Related]  

  • 31. Kinetic studies of phagocytosis. IV. Cellular defects and humoral inhibition as causes of impaired neutrophil phagocytosis in sarcoidosis.
    Hällgren R; Håkansson L; Schmekel B; Stålenheim G; Venge P
    Clin Exp Immunol; 1982 Jan; 47(1):169-75. PubMed ID: 7094421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on the responsiveness of alveolar T cells to proliferative stimuli and on surface antigens].
    Yamaguchi E
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):224-36. PubMed ID: 8509065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative study of tuberculin sensitivity in sarcoidosis and tuberculosis patients].
    Goncharova SI; Chernushenko EF
    Probl Tuberk; 1983 Jan; (1):39-43. PubMed ID: 6835965
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunological phenomenons connected with etiology and pathogenesis of sarcoidosis].
    Mamełka B; Faber M; Chciałowski A; Płusa T
    Pol Merkur Lekarski; 2002 Jun; 12(72):522-5. PubMed ID: 12362675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA association with sarcoidosis and diffuse interstitial pulmonary fibrosis.
    Mahbubani V; Trikannad VS; Sainani GS
    J Assoc Physicians India; 1995 Jan; 43(1):28-9. PubMed ID: 9282635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lymphocytotoxicity of serum and its development during ganglio-pulmonary sarcoidosis].
    Brun J; Biot N; Carraz M; Veysseyre C; Prevot J; Perrin-Fayolle M; Traeger J
    Lyon Med; 1969 Jan; 221(4):141-57. PubMed ID: 5779297
    [No Abstract]   [Full Text] [Related]  

  • 37. Isolation and characterization of an immunosuppressive protein in serum of patients with sarcoidosis.
    Göring HD; Lukowsky A; Schubert H; Schwalm I; Leib I
    Dermatol Monatsschr; 1984; 170(2):96-101. PubMed ID: 6724068
    [No Abstract]   [Full Text] [Related]  

  • 38. [Sarcoidosis from a new pulmonary perspective. Do antigenic peptides cause the inflammation?].
    Eklund A
    Lakartidningen; 1993 Sep; 90(36):2986-8. PubMed ID: 8366729
    [No Abstract]   [Full Text] [Related]  

  • 39. [The immunobiology of pulmonary granulomatosis].
    Farga V
    Rev Med Chil; 1984 Nov; 112(11):1172-3. PubMed ID: 6537014
    [No Abstract]   [Full Text] [Related]  

  • 40. [Chemotactic modifications in polymorphonuclear leukocytes (PMN) in sarcoidosis and anergizing diseases].
    Melloni CF; Melloni GF; Lureti GF; Minoja G
    Boll Soc Ital Biol Sper; 1977 Dec; 53(23):2258-63. PubMed ID: 610742
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.